Dianthus Therapeutics, Inc. is a biotechnology company focused on developing and commercializing novel therapies for cancer treatment. The company specializes in the design of monoclonal antibodies that target specific cancer cells, aiming to improve patient outcomes. Dianthus operates primarily in the oncology sector, serving healthcare providers and patients in the biopharmaceutical market. Its research and development efforts are concentrated in the United States.
